Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05721131 · ClinicalTrials.gov registry record

NC Thermometer (Gen 3) ISO 80601-2-56 Validation

A clinical trial of Healthy and Fever, sponsored by Natural Cycles.

Completed
Registry status
105
Enrollment target
2
Study locations

NCT05721131 is a study of Healthy and Fever that has completed, run by Natural Cycles. The registered enrollment target is 105 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05721131, a study of Healthy and Fever, has completed, sponsored by Natural Cycles.

COMPLETED
Registry status
105 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this clinical validation is to evaluate the the clinical bias, the limits of agreement, and the clinical repeatability of measuring oral temperature using a new thermometer, NC° Thermometer (Gen 3), compared to a reference clinical thermometer.

Interventions

  • DEVICE NC° Thermometer (Gen 3)

Study Locations (2)

California

  • Choice Health Network- Reyes Health Center - Anaheim

New York

  • Natural Cycles - New York

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2023-01-10
Est. Completion 2023-04-27

Sponsor

Natural Cycles

2 total trials

What the Registry Record Tells You About NCT05721131

The ClinicalTrials.gov registry entry for NCT05721131 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (84% lower). The listed sponsor is Natural Cycles, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which NC° Thermometer (Gen 3) is the first listed.

NCT05721131 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New York.

Frequently Asked Questions

What is clinical trial NCT05721131 about?

NCT05721131 is a clinical study titled "NC Thermometer (Gen 3) ISO 80601-2-56 Validation". The purpose of this clinical validation is to evaluate the the clinical bias, the limits of agreement, and the clinical repeatability of measuring oral temperature using a new thermometer, NC° Thermometer (Gen 3), compared to a reference clinical thermometer.

What is the current status of trial NCT05721131?

This trial is currently completed. The enrollment target is 105 participants. The study started on 2023-01-10. Estimated completion is 2023-04-27.

What conditions does trial NCT05721131 study?

This clinical trial studies the following conditions: Healthy, Fever, Febrile Illness.

What interventions are being tested in trial NCT05721131?

The interventions under investigation include: NC° Thermometer (Gen 3) (DEVICE).

Who is sponsoring clinical trial NCT05721131?

This trial is sponsored by Natural Cycles, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05721131 being conducted?

This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.